INTERNATIONAL PATENT: NANJING ANJI BIOTECHNOLOGY CO., LTD., 南京安吉生物科技有限公司 FILES APPLICATION FOR "USE OF NOVEL MICROPEPTIDES MP1 AND MP2 IN TUMOR DIAGNOSIS AND TREATMENT"

GENEVA, April 17 -- NANJING ANJI BIOTECHNOLOGY CO., LTD. (6F, Block A7, Hongfeng Technology Park, Nanjing Economic-Technological Development AreaNanjing, Jiangsu 210033), 南京安吉生物科技有限公司 (中国江苏省南京市经济技术开发区红枫科技园A7栋6层) filed a patent application (PCT/CN2025/127039) for "USE OF NOVEL MICROPEPTIDES MP1 AND MP2 IN TUMOR DIAGNOSIS AND TREATMENT" on Oct 11, 2025. With publication no. WO/2026/077454, the details related to the patent application was published on Apr 16, 2026.

Notably, the patent application was submitt...